Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
non-small-cell-lung-cancernsclc
non-small cell lung cancer, skb264, nsclc, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 825253
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.